KL Acquisition Corp
KLAQU
NASDAQ Capital Market10.09
USD
+0.02
- -
KL Acquisition Corp
KLAQU
(NASDAQ Capital Market)
Recent
price
10.09
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- KL Acquisition Corp (KLAQU) is a blank check company whose principal business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The company focuses its search for an initial business combination primarily on life sciences, healthcare or healthcare-related sectors, including medical devices, diagnostics, life sciences tools and instrumentation; it pursues targets principally in the US and other developed countries but has no current operations or revenues. KL Acquisition Corp was founded in 2020 and maintains its headquarters at 111 West 33rd Street, Suite 1910, New York, New York. The company completed a $287.5 million initial public offering in January 2021, with units, Class A common stock and warrants trading on Nasdaq under the symbols KLAQU, KLAQ and KLAQW, respectively, led by Goldman Sachs as sole bookrunner. In December 2022, following the failure to identify and consummate a business combination within its mandated timeframe, KL Acquisition Corp's stockholders approved a charter amendment permitting early liquidation and redemption of all public shares, resulting in suspension of trading, delisting from Nasdaq and complete wind-down of operations by year-end.
KL Acquisition Corp Announces Closing of its Initial Public Offering and Full Exercise of Underwriter's Over-Allotment Option
U.S. IPO Weekly Recap: The New Year Kicks Off With 2 Biotech IPOs And A Tidal Wave Of SPACs
KL Acquisition Corp Announces Pricing of $250 Million Initial Public Offering